Anderson, Don H.

A common haplotype in the complement regulatory gene factor H ( HF1/CFH ) predisposes individuals to age-related macular degeneration

Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences

Retinal Diseases and TreatmentsComplement system in diseases

Cited by 1,961

A role for local inflammation in the formation of drusen in the aging eye

Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 1,087

Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 937

The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited

Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research

Retinal Diseases and TreatmentsComplement system in diseases

Cited by 727

Complement activation and inflammatory processes in Drusen formation and age related macular degeneration

Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research

Retinal Diseases and TreatmentsComplement system in diseases

Cited by 621

The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences

Retinal Diseases and TreatmentsAlzheimer's disease research and treatments

Cited by 447

A potential role for immune complex pathogenesis in drusen formation

JOHNSON, L. V., OZAKI, S., STAPLES, M. K., ERICKSON, P. A., & ANDERSON, D. H. (2000) · Experimental Eye Research

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 353

Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration

Anderson, D. H., Talaga, K. C., Rivest, A. J., Barron, E., Hageman, G. S., & Johnson, L. V. (2004) · Experimental Eye Research

Retinal Diseases and TreatmentsAlzheimer's disease research and treatments

Cited by 319

Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein

Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M. J., Lindeman, N., Anderson, D. H., Johnson, P. T., Järvelä, I., Jokiranta, T. S., et al. (2007) · The Journal of Immunology

Complement system in diseasesRetinal Diseases and Treatments

Cited by 246

Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells

Hageman, G. S., Mullins, R. F., Russell, S. R., Johnson, L. V., & Anderson, D. H. (1999) · The FASEB Journal

Retinal Diseases and TreatmentsRetinal Development and Disorders

Cited by 206